An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
The EVAR 1 trial found that endovascular aneurysm repair (EVAR) offers a clear operative mortality benefit over open repair in patients who are fit for both procedures, but this early benefit is not translated into a long-term survival advantage. The EVAR 2 trial found that for patients who are not considered fit enough for open repair, EVAR does appear to reduce abdominal aortic aneurysm (AAA) rupture, but this does not lead to any improvement in survival as other serious comorbidities continue to contribute to a very high mortality overall.
1 Vascular Surgery Research Group, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London, UK
2 Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge, UK
3 Centre for Health Economics, University of York, York, UK
* Corresponding author Email: r.greenhalgh@imperial.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document